Wordt geladen...
Vaccine adjuvants as potential cancer immunotherapeutics
Accumulated evidence obtained from various clinical trials and animal studies suggested that cancer vaccines need better adjuvants than those that are currently licensed, which include the most commonly used alum and incomplete Freund’s adjuvant, because of either a lack of potent anti-tumor immunit...
Bewaard in:
| Gepubliceerd in: | Int Immunol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4922024/ https://ncbi.nlm.nih.gov/pubmed/27006304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/intimm/dxw015 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|